These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28536997)

  • 1. PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in Male Multiple Sclerosis Patients.
    Qureshi M; Hatem M; Alroughani R; Jacob SP; Al-Temaimi RA
    Neuromolecular Med; 2017 Sep; 19(2-3):286-292. PubMed ID: 28536997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin-Plexin Signaling: From Axonal Guidance to a New X-Linked Intellectual Disability Syndrome.
    Steele JL; Morrow MM; Sarnat HB; Alkhunaizi E; Brandt T; Chitayat DA; DeFilippo CP; Douglas GV; Dubbs HA; Elloumi HZ; Glassford MR; Hannibal MC; Héron B; Kim LE; Marco EJ; Mignot C; Monaghan KG; Myers KA; Parikh S; Quinonez SC; Rajabi F; Shankar SP; Shinawi MS; van de Kamp JJP; Veerapandiyan A; Waldman AT; Graf WD
    Pediatr Neurol; 2022 Jan; 126():65-73. PubMed ID: 34740135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the IL-10 receptor A536G (S138G) loss-of-function variant with multiple sclerosis in Tunisian patients.
    Ben Fredj N; Aissi M; Ben Selma W; Mahmoud I; Nefzi F; Frih-Ayed M; Boukadida J; Aouni M
    APMIS; 2017 May; 125(5):444-451. PubMed ID: 28225209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
    Dominguez-Mozo MI; Garcia-Montojo M; López-Cavanillas M; De Las Heras V; Garcia-Martinez A; Arias-Leal AM; Casanova I; Urcelay E; Arroyo R; Alvarez-Lafuente R
    Eur J Neurol; 2014 Mar; 21(3):537-40. PubMed ID: 23731219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication analysis of variants associated with multiple sclerosis risk.
    Dashti M; Ateyah K; Alroughani R; Al-Temaimi R
    Sci Rep; 2020 Apr; 10(1):7327. PubMed ID: 32355262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait.
    Dashti M; Alroughani R; Jacob S; Al-Temaimi R
    Mult Scler Relat Disord; 2019 Nov; 36():101409. PubMed ID: 31563075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
    Sadovnick AD; Traboulsee AL; Bernales CQ; Ross JP; Forwell AL; Yee IM; Guillot-Noel L; Fontaine B; Cournu-Rebeix I; Alcina A; Fedetz M; Izquierdo G; Matesanz F; Hilven K; Dubois B; Goris A; Astobiza I; Alloza I; Antigüedad A; Vandenbroeck K; Akkad DA; Aktas O; Blaschke P; Buttmann M; Chan A; Epplen JT; Gerdes LA; Kroner A; Kubisch C; Kümpfel T; Lohse P; Rieckmann P; Zettl UK; Zipp F; Bertram L; Lill CM; Fernandez O; Urbaneja P; Leyva L; Alvarez-Cermeño JC; Arroyo R; Garagorri AM; García-Martínez A; Villar LM; Urcelay E; Malhotra S; Montalban X; Comabella M; Berger T; Fazekas F; Reindl M; Schmied MC; Zimprich A; Vilariño-Güell C
    G3 (Bethesda); 2016 Jul; 6(7):2073-9. PubMed ID: 27194806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of plasma biomarkers for their association with Multiple Sclerosis progression.
    Jacob S; Al-Kandari A; Alroughani R; Al-Temaimi R
    J Neuroimmunol; 2017 Apr; 305():5-8. PubMed ID: 28284345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
    Al-Temaimi RA; Al-Enezi A; Al-Serri A; Alroughani R; Al-Mulla F
    PLoS One; 2015; 10(11):e0142265. PubMed ID: 26540116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroitin sulfate β-1,4-N-acetylgalactosaminyltransferase-1 (ChGn-1) polymorphism: Association with progression of multiple sclerosis.
    Saigoh K; Yoshimura S; Izumikawa T; Miyata S; Tabara Y; Matsushita T; Miki T; Miyamoto K; Hirano M; Kitagawa H; Kira J; Kusunoki S
    Neurosci Res; 2016 Jul; 108():55-9. PubMed ID: 26806424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
    AlFadhli S; Mohammed EM; Al Shubaili A
    Ann Hum Biol; 2013 Jul; 40(4):368-75. PubMed ID: 23826716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
    Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.
    Shawkatová I; Javor J; Párnická Z; Bucová M; Čopíková-Cudráková D; Michalík J; Gmitterová K; Čierny D; Buc M; Ďurmanová V
    Folia Microbiol (Praha); 2017 Jul; 62(4):287-293. PubMed ID: 28130760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population.
    Al-Shammri S; Nelson RF; Al-Muzairi I; Akanji AO
    Mult Scler; 2004 Aug; 10(4):381-6. PubMed ID: 15327033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALCAM and CD6--multiple sclerosis risk factors.
    Wagner M; Bilinska M; Pokryszko-Dragan A; Sobczynski M; Cyrul M; Kusnierczyk P; Jasek M
    J Neuroimmunol; 2014 Nov; 276(1-2):98-103. PubMed ID: 25216742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OAS1: a multiple sclerosis susceptibility gene that influences disease severity.
    O'Brien M; Lonergan R; Costelloe L; O'Rourke K; Fletcher JM; Kinsella K; Sweeney C; Antonelli G; Mills KH; O'Farrelly C; Hutchinson M; Tubridy N
    Neurology; 2010 Aug; 75(5):411-8. PubMed ID: 20679634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.